Lipocine doses first patient in Phase III postpartum depression study
Lipocine has dosed the first patient in a Phase III trial assessing LPCN 1154 (oral brexanolone) for the treatment of…
Lipocine has dosed the first patient in a Phase III trial assessing LPCN 1154 (oral brexanolone) for the treatment of…
Teva Pharmaceuticals has announced plans to halt a Phase II clinical trial evaluating emrusolmin (TEV-'286) to treat adults with multiple…
Shanghai Zhimeng Biopharma has completed patient enrolment in the pivotal Phase II/III clinical trial of its investigational potassium-channel opener, CB03-154,…